Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Outperform Centrica (CNA) by RBC Capital
- Sector Perform M&G (MNG) by RBC Capital
- Buy Sirius Real Estate Ltd. (SRE) by Jefferies
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Bank of America
- Sell Ocean Harvest Technology Group (OHT) by Steve Moore in ShareProphets
- Buy Synectics (SNX) by Hot Stock Rockets in ShareProphets
- Watch Standard Chartered (STAN) by Dr. James Fox in The Motley Fool
- Sell Genflow Biosciences (GENF) by Tom Winnifrith in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Buy Bluebird Mining Ventures Ltd NPV (DI) (BMV) by Hot Stock Rockets in ShareProphets
- Buy Eco buildings Group (ECOB) by Hot Stock Rockets in ShareProphets
- Buy Standard Chartered (STAN) by Simon Watkins in The Motley Fool
- Neutral Aston Martin Lagonda Global Holdings (AML) by Citi
- Buy Spirax Group (SPX) by Jefferies
- Neutral Great Portland Estates (GPE) by UBS
- Buy Shell (SHEL) by Simon Watkins in The Motley Fool
- Neutral Deliveroo Class (ROO) by Bryan Garnier
- Buy International Workplace Group (IWG) by Jefferies
- Buy Shaftesbury Capital (SHC) by Deutsche Bank
- Neutral Deliveroo Class (ROO) by UBS
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,388 open tips for GSK (GSK)
| Latest Bid : 1,399.00p | Latest Ask : 1,400.00p |
| High Today : 1,405.50p | Low Today : 1,328.50p |
| This Years High : 1,812.50p | This Years Low : 1,264.00p |
| Volume : 8,251,062 | MKT Cap : £58030M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Simon Watkins | Premium Only | 2025-05-07 07:25:00 07/05/2025 | 0.65% |
| Underweight | Morgan Stanley | Premium Only | 2025-05-07 06:59:00 07/05/2025 | 3.38% |
| Watch | Dr. James Fox | Premium Only | 2025-05-06 06:10:00 06/05/2025 | – |
| Neutral | Goldman Sachs | Premium Only | 2025-05-01 07:00:00 01/05/2025 | – |
| Underweight | JP Morgan | Premium Only | 2025-05-01 05:00:00 01/05/2025 | 0.61% |
| Latest Bid : 1,399.00p | Latest Ask : 1,400.00p |
| High Today : 1,405.50p | Low Today : 1,328.50p |
| This Years High : 1,812.50p | This Years Low : 1,264.00p |
| Volume : 8,251,062 | MKT Cap : £58030M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Simon Watkins | Premium Only | 2025-05-07 07:25:00 07/05/2025 | 0.65% |
| Underweight | Morgan Stanley | Premium Only | 2025-05-07 06:59:00 07/05/2025 | 3.38% |
| Watch | Dr. James Fox | Premium Only | 2025-05-06 06:10:00 06/05/2025 | – |
| Neutral | Goldman Sachs | Premium Only | 2025-05-01 07:00:00 01/05/2025 | – |
| Underweight | JP Morgan | Premium Only | 2025-05-01 05:00:00 01/05/2025 | 0.61% |